Carl D. Davis

935 total citations
29 papers, 575 citations indexed

About

Carl D. Davis is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Carl D. Davis has authored 29 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 9 papers in Psychiatry and Mental health. Recurrent topics in Carl D. Davis's work include Neuropeptides and Animal Physiology (10 papers), Migraine and Headache Studies (8 papers) and Receptor Mechanisms and Signaling (8 papers). Carl D. Davis is often cited by papers focused on Neuropeptides and Animal Physiology (10 papers), Migraine and Headache Studies (8 papers) and Receptor Mechanisms and Signaling (8 papers). Carl D. Davis collaborates with scholars based in United States, Germany and United Kingdom. Carl D. Davis's co-authors include Michael Sinz, A. David Rodrigues, Hongjian Zhang, Narender R. Gavva, Weiya Wang, Sonya G. Lehto, Sara Rao, Dawn Zhu, John E. Macor and Cen Xu and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Journal of Pharmaceutical Sciences.

In The Last Decade

Carl D. Davis

29 papers receiving 555 citations

Peers

Carl D. Davis
Maria Beconi United States
Szczepan Mogilski Poland
Abhijeet Kapoor United States
Charles A. Blum United States
Sonia Gallego‐Sandín Spain
Małgorzata Zygmunt Poland
Ing‐Jun Chen Taiwan
Brian Scott United States
Mark E. McDonnell United States
Craig R. Schneider United States
Maria Beconi United States
Carl D. Davis
Citations per year, relative to Carl D. Davis Carl D. Davis (= 1×) peers Maria Beconi

Countries citing papers authored by Carl D. Davis

Since Specialization
Citations

This map shows the geographic impact of Carl D. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl D. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl D. Davis more than expected).

Fields of papers citing papers by Carl D. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl D. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl D. Davis. The network helps show where Carl D. Davis may publish in the future.

Co-authorship network of co-authors of Carl D. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Carl D. Davis. A scholar is included among the top collaborators of Carl D. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl D. Davis. Carl D. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryu, Sangwoo, Woodrow Burchett, Carl D. Davis, et al.. (2023). Comparison of Tumor Binding Across Tumor Types and Cell Lines to Support Free Drug Considerations for Oncology Drug Discovery. Journal of Pharmaceutical Sciences. 113(3). 826–835. 1 indexed citations
2.
Luo, Guanglin, Ling Chen, Charles M. Conway, et al.. (2021). Calcitonin gene-related peptide (CGRP) receptor antagonists: Heterocyclic modification of a novel azepinone lead. Bioorganic & Medicinal Chemistry Letters. 43. 128077–128077. 2 indexed citations
3.
Mercer, Stephen E., Charles M. Conway, Deborah A. Cook, et al.. (2020). Azepino-indazoles as calcitonin gene-related peptide (CGRP) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 31. 127624–127624. 16 indexed citations
4.
Hu, Essa, Ning Chen, Roxanne K. Kunz, et al.. (2016). Discovery of Phosphodiesterase 10A (PDE10A) PET Tracer AMG 580 to Support Clinical Studies. ACS Medicinal Chemistry Letters. 7(7). 719–723. 4 indexed citations
5.
Degnan, Andrew P., Ying Han, Ramkumar Rajamani, et al.. (2015). Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(15). 3039–3043. 5 indexed citations
6.
Hwang, Dah‐Ren, Essa Hu, Jennifer R. Allen, et al.. (2015). Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates. Nuclear Medicine and Biology. 42(8). 654–663. 9 indexed citations
7.
Kiang, Y.-H., Eric A. Bercot, Qiong Wu, et al.. (2015). Selection of a Suitable Physical Form and Development of a Crystallization Process for a PDE10A Inhibitor Exhibiting Enantiotropic Polymorphism. Organic Process Research & Development. 19(12). 1849–1858. 5 indexed citations
8.
Lehto, Sonya G., Andy Weyer, Maosheng Zhang, et al.. (2015). AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(4). 465–476. 24 indexed citations
9.
Wu, Yong‐Jin, Huan He, Qi Gao, et al.. (2014). Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist–serotonin reuptake transporter inhibitor. Bioorganic & Medicinal Chemistry Letters. 24(6). 1611–1614. 4 indexed citations
10.
Hwang, Dah‐Ren, Essa Hu, John Castrillon, et al.. (2014). Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates. Nuclear Medicine and Biology. 41(4). 343–349. 19 indexed citations
11.
Lelas, Snježana, Yu-Wen Li, Matthew T. Taber, et al.. (2013). NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the Gerbil forced swim test. Neuropharmacology. 73. 232–240. 5 indexed citations
12.
Wu, Yong‐Jin, Huan He, Robert L. Bertekap, et al.. (2013). Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists–serotonin reuptake transporter inhibitors for the treatment of depression. Bioorganic & Medicinal Chemistry. 21(8). 2217–2228. 20 indexed citations
13.
Han, Xiaojun, Rita L. Civiello, Charles M. Conway, et al.. (2013). The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 2. Bioorganic & Medicinal Chemistry Letters. 23(6). 1870–1873. 7 indexed citations
14.
15.
Han, Xiaojun, Rita L. Civiello, Charles M. Conway, et al.. (2012). The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 1. Bioorganic & Medicinal Chemistry Letters. 22(14). 4723–4727. 9 indexed citations
16.
Davis, Carl D. & Cen Xu. (2008). The Tortuous Road to an Ideal CGRP Function Blocker for the Treatment of Migraine. Current Topics in Medicinal Chemistry. 8(16). 1468–1479. 3 indexed citations
17.
Zhang, Hongjian, Carl D. Davis, Michael Sinz, & A. David Rodrigues. (2007). Cytochrome P450 reaction-phenotyping: an industrial perspective. Expert Opinion on Drug Metabolism & Toxicology. 3(5). 667–687. 2 indexed citations
18.
Zhang, Donglu, Lifei Wang, Gamini Chandrasena, et al.. (2006). Involvement of Multiple Cytochrome P450 and UDP-Glucuronosyltransferase Enzymes in the in Vitro Metabolism of Muraglitazar. Drug Metabolism and Disposition. 35(1). 139–149. 21 indexed citations
19.
Wilson, A. S., Dominic P. Williams, Carl D. Davis, Malcolm D. Tingle, & B.Kevin Park. (1997). Bioactivation and inactivation of aflatoxin B1 by human, mouse and rat liver preparations: Effect on SCE in human mononuclear leucocytes. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 373(2). 257–264. 13 indexed citations
20.
Davis, Carl D., et al.. (1995). Kinetic parameters of lymphocyte microsomal epoxide hydrolase in carbamazepine hypersensitive patients. Biochemical Pharmacology. 50(9). 1361–1366. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Beconi Breakdown of academic impact, for papers by Szczepan Mogilski Breakdown of academic impact, for papers by Abhijeet Kapoor Breakdown of academic impact, for papers by Charles A. Blum Breakdown of academic impact, for papers by Sonia Gallego‐Sandín Breakdown of academic impact, for papers by Małgorzata Zygmunt Breakdown of academic impact, for papers by Ing‐Jun Chen Breakdown of academic impact, for papers by Brian Scott Breakdown of academic impact, for papers by Mark E. McDonnell Breakdown of academic impact, for papers by Craig R. Schneider
Rankless by CCL
2026